Track topics on Twitter Track topics that are important to you
We have read with interest the comment by Dr Abdelmaksoud and Dr Vestita to our recently published article concerning a fatal occurrence of acquired haemophilia A (AHA) in a patient with pemphigus vulgaris (PV) . In this comment, the authors pointed out the possible presence of a smouldering haematologic malignancy (HM) in our patient, since both AHA and PV have been found to be associated with haematologic cancers, and in particular, lymphoproliferative disorders.
This article was published in the following journal.
Name: Clinical and experimental dermatology
Acquired haemophilia A (AHA) is a rare autoimmune bleeding disorder caused by the presence of autoantibodies against coagulation factor VIII (FVIII). The mortality rate remains high. International rec...
Epidemiological surveillance of haemophilia through linkage of medical records within a US state has not been conducted in 20 years.
I read with interest a case report by Affleck et al. published in the journal of Clinical and Experimental Dermatology. The authors presented an 80-year-old patient on low-dose methotrexate (MXT) who...
Life expectancy of hemophilia patients has improved considerably during the past decades and is approaching that of the general population. Hemophilia patients are therefore likely to be c...
This study aims to make an inventory of the condition and care of patients with haemophilia and carriers for haemophilia in Ivory Coast and to promote the use non substitutive strategies t...
Life expectancy of haemophilia patients (specially severe) has dramatically increase in the last decades, which lead to the apparition of aging diseases such as cardiovascular disease, wit...
This NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The primary aim is to observe the haemostatic efficacy of NovoSeven® treatment during routine practice in German clinic...
This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in ...
Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by the patient during the course of treatment.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
A coronavirus first reported in the summer of 2012 in a pneumonia patient in SAUDI ARABIA. It is related to SARS VIRUS. MERS-CoV has an estimated incubation period of 12 days and symptoms include renal failure and severe acute pneumonia with often fatal outcome.
The right of the patient or the patient's representative to make decisions with regard to the patient's dying.